Your browser doesn't support javascript.
loading
Case Report: Multidisciplinary management of primary inferior vena cava leiomyosarcoma: a comprehensive case study.
Li, Wuchao; Zhang, Xiaoyong; Zhang, Yi; Wang, Rongpin.
  • Li W; Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Zhang X; Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Zhang Y; Department of Hepatobiliary Surgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Wang R; Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Front Oncol ; 13: 1190276, 2023.
Article en En | MEDLINE | ID: mdl-38023228
Introduction: Primary Inferior vena cava (IVC) leiomyosarcoma, a rare malignant tumor, presents unique challenges in diagnosis and treatment due to its rarity and the lack of consensus on surgical and adjuvant therapy approaches. Case Report: A 39-year-old female patient presented with lower limb swelling and mild fatigue. Contrast-enhanced CT identified a tumor mass within the dilated IVC. Abdominal MRI revealed primary IVC leiomyosarcoma extending into the right hepatic vein. A multidisciplinary consultation established a diagnosis and devised a treatment plan, opting for Ex-vivo Liver Resection and Auto-transplantation (ELRA), tumor resection and IVC reconstruction. Pathological examination confirmed primary IVC leiomyosarcoma. Postoperatively, the patient underwent a comprehensive treatment strategy that included radiochemotherapy, immunotherapy, targeted therapy, and PRaG therapy (PD-1 inhibitor, Radiotherapy, and Granulocyte-macrophage colony-stimulating factor). Despite the tumor's recurrence and metastasis, the disease progression was partially controlled. Conclusion: This case report emphasizes the complexities of diagnosing and treating IVC leiomyosarcoma and highlights the potential benefits of employing ELRA, IVC reconstruction, and PRaG therapy. Our study may serve as a valuable reference for future investigations addressing the management of this rare disease.
Palabras clave